IL326408A - Pharmaceutical formulation comprising a coated tablet - Google Patents

Pharmaceutical formulation comprising a coated tablet

Info

Publication number
IL326408A
IL326408A IL326408A IL32640826A IL326408A IL 326408 A IL326408 A IL 326408A IL 326408 A IL326408 A IL 326408A IL 32640826 A IL32640826 A IL 32640826A IL 326408 A IL326408 A IL 326408A
Authority
IL
Israel
Prior art keywords
pharmaceutical formulation
coated tablet
tablet
coated
formulation
Prior art date
Application number
IL326408A
Other languages
Hebrew (he)
Original Assignee
Hoffmann La Roche
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche, Genentech Inc filed Critical Hoffmann La Roche
Publication of IL326408A publication Critical patent/IL326408A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
IL326408A 2023-08-11 2024-08-09 Pharmaceutical formulation comprising a coated tablet IL326408A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363532164P 2023-08-11 2023-08-11
PCT/EP2024/072652 WO2025036856A1 (en) 2023-08-11 2024-08-09 Pharmaceutical formulation comprising a coated tablet

Publications (1)

Publication Number Publication Date
IL326408A true IL326408A (en) 2026-04-01

Family

ID=92409277

Family Applications (1)

Application Number Title Priority Date Filing Date
IL326408A IL326408A (en) 2023-08-11 2024-08-09 Pharmaceutical formulation comprising a coated tablet

Country Status (6)

Country Link
KR (1) KR20260049827A (en)
AU (1) AU2024326203A1 (en)
IL (1) IL326408A (en)
MX (1) MX2026001521A (en)
TW (1) TW202506112A (en)
WO (1) WO2025036856A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274327B1 (en) 1992-04-13 2001-08-14 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
GB9208135D0 (en) 1992-04-13 1992-05-27 Ludwig Inst Cancer Res Polypeptides having kinase activity,their preparation and use
US5846824A (en) 1994-02-07 1998-12-08 Ludwig Institute For Cancer Research Polypeptides having kinase activity, their preparation and use
AU2016287463B2 (en) 2015-07-02 2020-07-02 F. Hoffmann-La Roche Ag Benzoxazepin oxazolidinone compounds and methods of use
WO2018109204A1 (en) 2016-12-15 2018-06-21 F. Hoffmann-La Roche Ag Process for the preparation of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino) propanamide
TW202011966A (en) * 2018-07-23 2020-04-01 瑞士商赫孚孟拉羅股份公司 Methods of treating cancer with pi3k inhibitor, gdc-0077
WO2023044386A1 (en) * 2021-09-15 2023-03-23 Thomas Jefferson University Composition for treating, preventing, or ameliorating melanoma and method thereof
CN116120341A (en) * 2021-11-12 2023-05-16 杭州领业医药科技有限公司 Crystal form of GDC-0077 and preparation method and application thereof
WO2023250343A1 (en) * 2022-06-21 2023-12-28 Loxo Oncology, Inc. Bcl2 formulations

Also Published As

Publication number Publication date
TW202506112A (en) 2025-02-16
WO2025036856A1 (en) 2025-02-20
MX2026001521A (en) 2026-03-02
AU2024326203A1 (en) 2026-02-19
KR20260049827A (en) 2026-04-14

Similar Documents

Publication Publication Date Title
CA224159S (en) Oral dosage tablet
GB202010230D0 (en) Pharmaceutical formulation
EP4238556A4 (en) Gastroretentive pharmaceutical dosage form
IL326408A (en) Pharmaceutical formulation comprising a coated tablet
GB202100526D0 (en) Pharmaceutical formulation
CA3301297A1 (en) Pharmaceutical formulation comprising a coated tablet
IL314206A (en) Pharmaceutical formulation
IL297081A (en) Pharmaceutical formulation
IL321640A (en) Pharmaceutical formulation
IL319214A (en) Pharmaceutical formulation
GB202216467D0 (en) Pharmaceutical formulation
CA233334S (en) Pharmaceutical tablet
CA233333S (en) Pharmaceutical tablet
GB202203764D0 (en) Pharmaceutical formulation
EP4355847B8 (en) A unit dose tablet composition
PL4279075T3 (en) A pharmaceutical composition comprising elagolix
CA200107S (en) Pharmaceutical tablet
CA199175S (en) Pharmaceutical tablet
CA199173S (en) Pharmaceutical tablet
CA199170S (en) Pharmaceutical tablet
CA220130S (en) Delivery dose tablet
CA3305818A1 (en) Tablet formulation
AU2024355141A1 (en) Tablet formulation
GB202209047D0 (en) A coating for a tablet
AU2023903165A0 (en) Tablet formulation